Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H23N3S2 |
Molecular Weight | 297.483 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCSC1=NSN=C1C2=CCCN(C)C2
InChI
InChIKey=XUHMGFKQBWZWPO-UHFFFAOYSA-N
InChI=1S/C14H23N3S2/c1-3-4-5-6-10-18-14-13(15-19-16-14)12-8-7-9-17(2)11-12/h8H,3-7,9-11H2,1-2H3
Molecular Formula | C14H23N3S2 |
Molecular Weight | 297.483 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Tazomeline (also known as LY 287041), a neuropsychiatric agent, is a muscarinic M1 acetylcholine receptor agonist that was studied in patients with cognitive dysfunction. Tazomeline participated in clinical trials for the treatment of Alzheimer’s disease and dementia. However, all these studied were discontinued for unknown reasons.
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:17:22 GMT 2023
by
admin
on
Fri Dec 15 17:17:22 GMT 2023
|
Record UNII |
QDP6S14W5W
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C47796
Created by
admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
131460
Created by
admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
|
PRIMARY | |||
|
QDP6S14W5W
Created by
admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
|
PRIMARY | |||
|
7629
Created by
admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
|
PRIMARY | |||
|
CHEMBL131819
Created by
admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
|
PRIMARY | |||
|
100000082454
Created by
admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
|
PRIMARY | |||
|
SUB10852MIG
Created by
admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
|
PRIMARY | |||
|
C87693
Created by
admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
|
PRIMARY | |||
|
DTXSID80157288
Created by
admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
|
PRIMARY | |||
|
131987-54-7
Created by
admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
|
PRIMARY | |||
|
Tazomeline
Created by
admin on Fri Dec 15 17:17:22 GMT 2023 , Edited by admin on Fri Dec 15 17:17:22 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|